A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists' Interventions on Patient Outcome

Case Reports in Psychiatry
Mercy N A Opare-AddoGrace Owusu Aboagye

Abstract

Schizophrenia is a chronic and severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behaviour. This report presents the role of clinical pharmacists in the management of a patient diagnosed with schizophrenia with symptoms of paranoia. A gainfully employed young African male adult reported to be roaming around town moving from one bank to another was arrested. The patient was referred to the psychiatric unit of a hospital and diagnosed with schizophrenia. Key interventions offered included rapid tranquilization, electroconvulsive therapy, and psychotherapy. Medications administered to the patient while on admission included IV diazepam, IM haloperidol, IV Ketamine, IM flupentixol, olanzapine tablets, and trihexyphenidyl tablets. Issues raised by clinical pharmacists during the patient's admission included need for alternative medication for rapid tranquilization, need for initial investigations and documentation of the patient's vitals, initiation of antipsychotic therapy without initial monitoring and screening for substance abuse, inappropriate dose at initiation of antipsychotic medications, untreated indication, and incidence of missed doses. Interventions by th...Continue Reading

References

Feb 1, 1997·Journal of Clinical Pharmacy and Therapeutics·C P Alderman
Dec 26, 2003·Pharmacotherapy·Patrick R FinleyA John Rush
Jul 12, 2005·Schizophrenia Bulletin·Delbert G RobinsonJohn M Kane
Dec 4, 2009·Schizophrenia Bulletin·Robert W BuchananUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Feb 8, 2011·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Célia MantovaniCristina Marta Del-Ben
Feb 5, 2011·Journal of Psychopharmacology·Thomas R E Barnes, UNKNOWN Schizophrenia Consensus Group of British Association for Psychopharmacology
Dec 7, 2013·International Journal of Clinical Pharmacy·Tom E RichardsonTimothy F Chen
Feb 14, 2014·BMJ : British Medical Journal·Elizabeth KuipersTim Kendall
Oct 23, 2014·International Journal of Environmental Research and Public Health·Maria Rubio-ValeraClaire L O'Reilly
Jan 6, 2015·Psychiatry and Clinical Neurosciences·Paul P LernerVladimir Lerner
Feb 22, 2017·Indian Journal of Psychiatry·Sandeep GroverAjit Avasthi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The Australian and New Zealand Journal of Psychiatry
Claire L O'ReillyTimothy F Chen
Hospital & Community Psychiatry
C Salzman, S A Hoffman
The American Journal of Psychiatry
P Polak, L Laycob
The Western Journal of Medicine
N L Hoell
© 2021 Meta ULC. All rights reserved